Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cancer: early-phase trial registry
279 of 621 indexed Cancer trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #6 of 28,963 conditions by registered trial count.
621 US clinical trials · 279 currently recruiting · #6 of 28,963 conditions by registered trial count
Cancer: 621 US clinical trials tracked, 279 recruiting.
Cancer is the subject of 621 registered US clinical trials on ClinicalTrials.gov, 279 of them currently open to new participants. 31 are in Phase 3-4 (later-stage) and 164 in Phase 1-2 (earlier-stage). The most active sponsor is M.D. Anderson Cancer Center, running 31 of these trials.
Open enrollment, early-phase tilt
Cancer has 621 registered US clinical trials, 279 of them open to new participants right now, about 45% of the total.
- 279
- recruiting participants now
- 45%
- of trials open to enrollment
- 31
- in Phase 3-4 (later-stage)
- 31
- top sponsor: M.D. Anderson Cancer Center
Corpus placement: #6 of 28,963 conditions by registered trial count on ClinicalTrials.gov-derived indexes. Registry reference only, not medical advice.
Key findings
What ClinicalTrials.gov does not surface for Cancer on its own pages , computed from the registry mirror as of 2026-07-11. Each line carries its own denominator so it can be quoted as it stands.
-
Cancer is recruiting above its size-band peers.
279 of 621 indexed trials (44.9%) are open to enrollment, against a 37.2% average across 135 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Cancer trials is spread across many organizations.
M.D. Anderson Cancer Center accounts for 31 of 621 trials (5%). 270 distinct sponsors appear on at least one study for this condition label.
-
Typical Cancer enrolment sits around 108 participants.
Median target enrolment is 108 among the 616 trials that report a genuine target (sentinel values excluded). 287 of those (46.6%) plan for fewer than 100 participants.
-
Cancer research is mostly interventional.
462 interventional and 159 observational studies make up this index (74.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
621 total, page 4 of 13
Development of Brief Positive Affect Treatment (PAT) for Caregivers of Patients With Advanced Cancer
M.D. Anderson Cancer Center
NCT05904782
Radiotherapy Patient Education With Virtual Reality
University of Miami
NCT06506435
Remote Temperature Monitoring of Patients At Risk for Developing Fever
AION Biosystems
NCT06752512
A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors
EpicentRx
NCT04673942
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Conjupro Biotherapeutics
NCT05948865
Long-Term Follow-Up of Recipient of Gene Transfer Research
M.D. Anderson Cancer Center
NCT01492036
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
MBrace Therapeutics
NCT06014658
Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer
Virginia Commonwealth University
NCT05958316
Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
University of California, San Francisco
NCT06633224
A Study of Live Tumor Fragments of Surgical Resections
Mayo Clinic
NCT07000864
eMOTION: Examining Implicit Attitudes in Physical Activity Engagement
University of Southern California
NCT07044570
Healthy Living Anson Study
University of North Carolina, Chapel Hill
NCT07126587
Evaluating Microarray Pharmacogenetic Testing in Cancer Patients
Wake Forest University Health Sciences
NCT06489041
Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors
Barbara Ann Karmanos Cancer Institute
NCT06908629
Breast Re-irradiation After Second Ipsilateral Lumpectomy
Youssef Zeidan
NCT06867484
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors
Alterome Therapeutics
NCT06533059
Assessment of Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients
Thomas Jefferson University
NCT03245411
Chinese American Cancer Survivors Writing Study
New York University
NCT05456100
Tumor Related Epilepsy
National Institute of Neurological Disorders and Stroke (NINDS)
NCT02639325
Leading Healthy Eating and Activity Promotion Program
University of Alabama at Birmingham
NCT06868524
Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
University of Utah
NCT06484179
The PRISM-Social Needs (PRISM-SN) Intervention for Adolescents and Young Adults With Cancer
Seattle Children's Hospital
NCT06242964
EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for Cancer
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
NCT06083324
A Biobehavioral Intervention for Latino/Hispanic Young Adults with Cancer
University of California, Irvine
NCT06338475
Nourishing Hope: The Impact of Nutrition in Cancer Treatment and Recovery in Maine
Yale University
NCT07076004
The Florida ASCENT Study
University of Florida
NCT07042243
F.L.O.S.S. Project (Facilitated Lessons on Oral and Systemic Health in Survivors)
Georgetown University
NCT06315855
Young Adult Infusion Space Experience Satisfaction Survey
UNC Lineberger Comprehensive Cancer Center
NCT05720546
Pleuroscopy First Versus Thoracentesis First in Patients With Suspected Malignant Pleural Effusions
Icahn School of Medicine at Mount Sinai
NCT06892691
A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
National Cancer Institute (NCI)
NCT05588141
Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
Rachel Miller
NCT03089554
Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies
Replimune
NCT04349436
A Study of NTX-1088, a Monoclonal Antibody Targeting the Poliovirus Receptor (PVR, CD155), as Monotherapy and Combined With Pembrolizumab
Nectin Therapeutics
NCT05378425
Supportive Care Intervention for Outpatient Stem Cell Transplant Patients
Victor Wang
NCT06564233
Visual Communication: Digital Tool to Improve the Understanding of Treatment Options for Patients With Cancer and Increase Satisfaction of the Overall Experience for Patients, Caregivers, and Providers
NYU Langone Health
NCT06927050
Revealing Information Genuinely & Honestly Across Time - Communication Preferences Visit
St. Jude Children's Research Hospital
NCT06993688
A Youth-led Intervention to Reduce Healthcare Disparities in Cancer Screening
Rutgers, The State University of New Jersey
NCT07008781
Testing a Brief Motivational Intervention to Increase Physical Activity for Cancer Survivors
Stony Brook University
NCT07215091
Impact of Daily Oral Cannabis Doses in Patients With Cancer
Shanna Babalonis, PhD
NCT06601218
Validation of the Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Tool for Use in a Physical Medicine Rehabilitation Clinic
M.D. Anderson Cancer Center
NCT06329531
Patient Descriptors Of Cancer-Related Fatigue: A Mixed Methods Pilot Study Of Cancer Survivors
Wake Forest University Health Sciences
NCT06634381
Examining the Feasibility and Impact of a Clinic-based Food Farmacy and Digital Culinary Medicine Program Among Cancer Survivors Treated in a Safety Net Hospital
M.D. Anderson Cancer Center
NCT06760754
Resilience Mobile App for Teens and Young Adults With Cancer
Seattle Children's Hospital
NCT05842902
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Angiex
NCT06440005
Cancer and Mild Cognitive Impairment Dyadic Intervention
Duke University
NCT05144516
An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors
Shenzhen Ionova Life Sciences Co.
NCT04443088
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
Heike E Daldrup-Link
NCT01542879
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
M.D. Anderson Cancer Center
NCT07186556
Comprehensive Tobacco Cessation for Cancer Patients and Survivors
Virginia Commonwealth University
NCT05805722
BfedBwell Optimization Pilot
University of Colorado, Denver
NCT06184256
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 116 |
| Phase 2 | 48 |
| Phase 3 | 27 |
| Phase 4 | 4 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
What is open for Cancer right now
279 recruiting of 621 indexed (45% open).
Phase mix: 31 late (III/IV) vs 164 early (I/II) (early-phase heavy).
Top sponsor: M.D. Anderson Cancer Center (31 trials), 9 others listed. 50 shown below, recruiting first. #6 of 28,963 conditions by registered trial count.
How open-enrollment share is computed
Open share is recruiting_count divided by trial_count for this condition label in the public registry export. Status can change between pulls; treat the figure as a snapshot of research attention, not treatment availability.
Frequently Asked Questions
How many clinical trials are there for Cancer?
PlainTrial tracks 621 US clinical trials for Cancer, of which 279 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Cancer?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.